Skip to main content

Table 1 Characteristics of TA patients

From: Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis

  Total Active Inactive p
N 84 47 37  
Sex, female (%) 73 (86.90) 40 (85.11) 33 (89.19) 0.415
Age, years 31.88 ± 10.01 29.64 ± 8.78 34.73 ± 10.86 0.023
Disease duration, months 47.49 ± 66.03 34.96 ± 5.10 84.34 ± 13.87 0.001
Clinical manifestations
 Hypertension (%) 20 (23.81) 7 (14.89) 13 (35.14) 0.029
 Asymmetrical blood pressure (%) 3 (3.57) 3 (6.38) 0 0.170
 Pulseless (%) 6 (7.14) 6 (12.77) 0 0.032
 Fatigue (%) 7 (8.33) 7 (14.89) 0 0.016
 Dizziness (%) 9 (10.71) 8 (17.02) 1 (2.70) 0.035
 Neck pain (%) 14 (16.67) 14 (29.79) 0 < 0.001
 Fever (%) 3 (3.57) 3 (6.38) 0 0.170
Received therapies (%) 49 (58.33) 20 (42.55) 29 (78.38) 0.001
Laboratory examination
 ESR, mm/H 37.46 ± 32.95 50.72 ± 34.55 20.53 ± 21.25 < 0.001
 CRP, mg/L 27.13 ± 44.19 41.37 ± 53.85 8.53 ± 11.66 0.001
 SAA, mg/L 99.71 ± 176.38 144.01 ± 212.72 32.29 ± 52.87 0.017
 Platelet count, ×109/L 301.23 ± 110.81 327.85 ± 123.58 267.22 ± 81.64 0.013
 Kerr scores 1.89 ± 1.05 2.40 ± 0.92 1.24 ± 0.83 < 0.001
 ITAS 2010 scores 3.43 ± 4.73 4.68 ± 4.93 1.84 ± 3.98 0.004
Ultrasound index
 Carotid artery wall thickness, mm 2.12 ± 0.77 2.36 ± 0.86 1.79 ± 0.49 0.001
 Carotid artery diameter, mm 3.73 ± 2.19 3.91 ± 1.92 3.48 ± 2.51 0.424
 Diffuse lesions (%) 72 (85.71) 40 (85.11) 32 (86.49) 0.557
 Proportions of vascular stenosis (%) 59 (70.24) 29 (61.70) 30 (81.08) 0.044
 Proportions of vascular occlusion (%) 10 (11.90) 2 (4.26) 8 (21.62) 0.019
 Carotid artery peak flow rate, m/s 1.37 ± 0.99 1.59 ± 1.04 1.08 ± 0.85 0.019
 Carotid RI 0.73 ± 0.13 0.73 ± 0.13 0.72 ± 0.13 0.915
 CEUS carotid wall vascularization grade 2 (%) 38 (45.24) 29 (61.70) 9 (24.32) 0.001
  1. TA Takayasu arteritis, ESR erythrocyte sedimentation rate, CRP C-reactive protein, SAA serum amyloid A, RI resistance index, CEUS contrast-enhanced ultrasonography